Geneve, Geneva, Switzerland The venture was found in Europe in Switzerland. The leading representative office of defined Corporate Investor is situated in the Geneva.
For fund there is no match between the location of its establishment and the land of its numerous investments - Denmark. Among the most popular portfolio startups of the fund, we may highlight Genmab, 7TM Pharma, ESBATech. The fund has specific favorite in a number of founders of portfolio startups. Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the most popular fund investment industries, there are Health Care, Therapeutics.
Speaking about the real fund results, this Corporate Investor is 3 percentage points less often commits exit comparing to other organizations. Comparing to the other companies, this LODH Immunology Fund performs on 4 percentage points more the average number of lead investments. The increased amount of exits for fund were in 2019. The high activity for fund was in 2000. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars.
The standard case for the fund is to invest in rounds with 4-5 partakers. Despite the LODH Immunology Fund, startups are often financed by Reference Capital SA, Novartis Venture Fund, Pictet Private Equity Investors S.A.. The meaningful sponsors for the fund in investment in the same round are Novartis Venture Fund, Pictet Private Equity Investors S.A., Index Ventures. In the next rounds fund is usually obtained by Novartis Venture Fund, BZ Bank, VI Partners AG.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Ascend Technology Ventures | - |
| Atwater Capital | California, Los Angeles, United States |
| Audley Institute | - |
| CTBC Financial Holding | Taipei, Taiwan |
| Haddad Advisory | - |
| IDN Financials | - |
| Iven | Beijing, Beijing, China |
| Lianbang Software | Beijing, Beijing, China |
| Martal Capital | Canada, Oakville, Ontario |
| New Europe Ventures, LLC | New York, New York, United States |
| North Haven Expansion Credit | - |
| OneTen Capital | Buffalo, New York, United States |
| Philippine National Bank | Pasay, Pasay City, Philippines |
| SMBC Nikko Securities Japan | - |
| Standing Oaks Venture Partners | - |
| Tri State Ventures | New York, New York, United States |
| Xiancheng Touzi | China, Putuo, Shanghai |
| Yangzhou Mandao Chuangye Touzi | China, Jiangsu, Yangzhou |
| Youzu Interactive | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
NovImmune | $46M | 01 Jun 2006 | Geneva, Switzerland | ||
ESBATech | $15M | 14 May 2002 | Zurich, Switzerland | ||
7TM Pharma | $15M | 27 Sep 2001 | Denmark, " Denmark"} | ||
NovImmune | $14M | 01 May 2000 | Geneva, Switzerland |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
NovImmune | $46M | 01 Jun 2006 | Geneva, Switzerland | ||
ESBATech | $15M | 14 May 2002 | Zurich, Switzerland | ||
7TM Pharma | $15M | 27 Sep 2001 | Denmark, " Denmark"} | ||
NovImmune | $14M | 01 May 2000 | Geneva, Switzerland |
